Aurobindo Pharma USA Inc. is recalling 4,464 bottles of Amlodipine and Olmesartan Medoxomil tablets (5 mg/40 mg), a prescription blood pressure medication. The recall was initiated after a pharmacist reported that the tablets in a specific lot were pink instead of the correct cream (peach) color. Using a medication that does not match its physical description can lead to confusion and incorrect dosing.
The tablets in the affected lot may be the wrong color, which indicates a potential manufacturing error or product mix-up. This poses a risk of medication error where a patient might take the wrong drug or dosage, potentially failing to control their blood pressure or experiencing unexpected side effects.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.